Papaverine

Papaverine

SCHEMBL9551009

COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC.COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 14/20 1.00
PDE3A Q14432 10/20 1.00
PDE3B Q13370 9/20 1.00
SMN1; SMN2 Q16637 5/20 1.00
CYP3A4 P08684 4/20 1.00
MAPK1 P28482 4/20 1.00
LMNA P02545 3/20 1.00
USP2 O75604 2/20 1.00
ALDH1A1 P00352 2/20 1.00
HIF1A Q16665 2/20 1.00
CYP1A2 P05177 2/20 1.00
CYP2C9 P11712 2/20 1.00
TSHR P16473 2/20 1.00
PDE4A P27815 2/20 1.00
KCNH2 Q12809 2/20 1.00
PDE4D Q08499 2/20 1.00
PDE2A O00408 1/20 1.00
ABCC4 O15439 1/20 1.00
PDE5A O76074 1/20 1.00
ABCB11 O95342 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Papaverine SCHEMBL29387160 1.00 PDE10A (1.00) PDE10APDE3APDE3BSMN1; SMN2CYP3A4
Papaverine SCHEMBL34702 1.00 PDE10A (1.00) PDE10APDE3APDE3BSMN1; SMN2CYP3A4
Papaverine SCHEMBL29360983 1.00 PDE10A (1.00) PDE10APDE3APDE3BSMN1; SMN2CYP3A4
Papaverine SCHEMBL28169527 0.99 PDE10A (0.97) PDE10APDE3APDE3BSMN1; SMN2CYP3A4
Papaverine SCHEMBL29696479 0.99 PDE10A (1.00) PDE10APDE3APDE3BSMN1; SMN2CYP3A4
Papaverine SCHEMBL8691148 0.99 PDE10A (0.97) PDE10APDE3APDE3BSMN1; SMN2CYP3A4
Papaverine SCHEMBL677440 0.99 PDE10A (0.97) PDE10APDE3APDE3BSMN1; SMN2CYP3A4
Papaverine SCHEMBL29356374 0.99 PDE10A (1.00) PDE10APDE3APDE3BSMN1; SMN2CYP3A4
Papaverine SCHEMBL9614479 0.99 PDE10A (1.00) PDE10APDE3APDE3BSMN1; SMN2CYP3A4
Papaverine SCHEMBL5500363 0.99 PDE10A (1.00) PDE10APDE3APDE3BSMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101398414-B Method for qualitatively screening 242 kinds of compounds by liquid phase chromatography-mass spectra at the same times CRIMINAL INVEST DEPT OF SHANGHAI POLICE STATION 2011-07-20 CN disclosed
CN-101398414-A Method for qualitatively screening 242 kinds of compounds by liquid phase chromatography-mass spectra at the same times CRIMINAL INVEST GENERAL UNIT O (CN) 2009-04-01 CN disclosed
US-5256652-A Administering peripheral vasodilator and hydroxy-B-cyclo-dextrin to enhance erection PHARMEDIC CO. (US) 1993-10-26 US disclosed
US-4849412-A PAPAVERINE COMPOUND, NUCLEOSIDE ANALOG BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1989-07-18 US disclosed
US-4800081-A CALCIUM INFLUX BLOCKER SYNERGISTIC WITH INTERFERON OR CYCLIC NUCLEOTIDE MODULATOR BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1989-01-24 US disclosed